Table 3. Univariable and multivariable analysis of variables in relation to Hazard Ratio (HR) of pancreatic cancer patients who underwent resection in the Netherlands, period 2005–2011. (n = 3,381).
| Univariable | Multivariable | |||||
|---|---|---|---|---|---|---|
| % of patients | HR | 95% CI | HR | 95% CI | ||
| Type of hospital | University | 35 | 1 | Reference | 1 | Reference |
| Non-university, teaching | 40 | 1.2 | 1.1–1.3 | 1.2 | 1.13–1.33 | |
| Non-university, non teaching | 25 | 1.3 | 1.-149 | 1.5 | 1.33–1.61 | |
| Age | 65(median) | 1.01 | 1.0–1.02 | 1.01 | 1.00–1.02 | |
| Gender | Men | 54 | 1 | Reference | 1 | Reference |
| Women | 46 | 0.95 | 0.9–1.0 | 1.00 | 0.93–1.08 | |
| Differentiation | Well | 11 | 1 | Reference | 1 | Reference |
| Moderate | 44 | 1.3 | 1.2–1.5 | 1.3 | 1.12–1.44 | |
| Poor | 29 | 1.8 | 1.6–2.0 | 1.7 | 1.5–2.0 | |
| Undifferentiated | 0.3 | 1.3 | 0.6–2.6 | 0.9 | 0.5–1.9 | |
| Unknown | 17 | 1.0 | 0.9–1.2 | 1.1 | 0.96–1.27 | |
| Stage (TNM) | I | 26 | 1 | Reference | 1 | Reference |
| II | 44 | 1.5 | 1.9–2.8 | 1.5 | 1.35–1.63 | |
| III | 22 | 1.9 | 1.9–3.3 | 1.8 | 1.66–2.05 | |
| IV | 5 | 2.5 | 2.1–5.0 | 2.5 | 2.14–2.99 | |
| Unknown | 2 | 1.0 | 0.8–1.3 | 1.1 | 0.86–1.42 | |
| Adjuvant chemotherapy | No | 80 | 1 | Reference | 1 | Reference |
| Yes | 20 | 0.7 | 0.6–0.8 | 0.7 | 0.64–0.78 | |